Get started
Author

Diego Esteban Cargnelutti

Observed names: Cargnelutti, D. E., Cargnelutti, Diego Esteban, D E Cargnelutti, D. E. Cargnelutti, Diego Cargnelutti, Diego E Cargnelutti, Diego E. Cargnelutti, DiegoE Cargnelutti
Observed institutions: University of Mendoza, Aconcagua University, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de Cuyo, Centro Científico Tecnológico - Mendoza, Instituto de Medicina y Biología Experimental de Cuyo, National University of San Luis
ORCID: 0000-0002-1246-7551
Observed ORCID: 0000-0002-1246-7551
OpenAlex ID: A5047100943
Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
2014 · Maria Victoria Sanchez, Thomas Ebensen, et al. · PLoS ONE · 53
PDF
Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis
2022 · María José Germanó, Juan Pablo Mackern-Oberti, et al. · Frontiers in Immunology · 24
PDF
Make It Simple: (SR-A1+TLR7) Macrophage Targeted NANOarchaeosomes
2018 · Federico Leonel Parra, Ayelen Tatiana Caimi, et al. · Frontiers in Bioengineering and Biotechnology · 22
PDF
Total Leishmania antigens with Poly(I:C) induce Th1 protective response
2017 · M. V. Sanchez, R. J. Eliçabe, et al. · Parasite Immunology · 17
PDF
Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection
2014 · Diego Esteban Cargnelutti, María Cristina Salomón, et al. · Journal of Microbiology Immunology and Infection · 16
PDF
Development of a universal CTL-based vaccine for influenza
2013 · Diego Esteban Cargnelutti, María Victoria Sánchez, et al. · Bioengineered · 15
PDF
Desmoglein-4 Deficiency Exacerbates Psoriasiform Dermatitis in Rats While Psoriasis Patients Displayed a Decreased Gene Expression of DSG4
2021 · Tamara Moreno-Sosa, María Belén Sánchez, et al. · Frontiers in Immunology · 14
PDF
Enhancement of Th1 immune responses to recombinant influenza nucleoprotein by Ribi adjuvant.
2013 · Diego E Cargnelutti, María A V Sanchez, et al. · PubMed · 14
Antiparasitic Activity of Two Natural Terpenes from Salvia cuspidata against Leishmania amazonensis
2023 · Mariana Elizabeth Troncoso, María José Germanó, et al. · Journal of Natural Products · 13
Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response
2006 · M. S. Di Genaro, D. E. Cargnelutti, et al. · Rheumatology · 12
Leishmaniasis in the Argentine Republic: Temporal and geographical distribution from 2013 to 2017
2019 · DiegoE Cargnelutti, MaríaJ Germano, et al. · Asian Pacific Journal of Tropical Medicine · 10
PDF
Yersinia‐triggered arthritis in IL‐12p40‐deficient mice: relevant antigens and local expression of Toll‐like receptor mRNA
2007 · M. S. Di Genaro, D. E. Cargnelutti, et al. · Scandinavian Journal of Rheumatology · 10
Evaluation of different total Leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a Toll-like receptor-3 agonist to prevent cutaneous leishmaniasis
2020 · María José Germanó, Esteban Sebastián Lozano, et al. · Memórias do Instituto Oswaldo Cruz · 9
PDF
Diagnosis of Leishmania infection in a nonendemic area of South America
2014 · Diego Esteban Cargnelutti, Carlos Guillermo Borremans, et al. · Journal of Microbiology Immunology and Infection · 9
PDF
Leishmania (L.) amazonensis infection impairs reproductive and fetal parameters in female mice
2020 · María Belén Sánchez, María José Germanó, et al. · Revista Argentina de Microbiología · 8
PDF
[Human diphyllobothriosis. A case in non-endemic area of Argentina].
2012 · Diego E Cargnelutti, María Cristina Salomón · PubMed · 8
Improved Immune Response to Recombinant Influenza Nucleoprotein Formulated with ISCOMATRIX
2012 · Diego E. Cargnelutti · Journal of Microbiology and Biotechnology · 7
Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG
2023 · Maria Victoria Sanchez, Thomas Ebensen, et al. · Pharmaceutics · 5
PDF
Receptor‐binding domain‐based SARS‐CoV‐2 vaccine adjuvanted with cyclic di‐adenosine monophosphate enhances humoral and cellular immunity in mice
2023 · María José Germanó, Constanza Giai, et al. · Journal of Medical Virology · 5
PDF
Therapeutic effect of Prosopis strombulifera (LAM) BENTH aqueous extract on a murine model of cutaneous leishmaniasis
2021 · Esteban Sebastián Lozano, María José Germanó, et al. · Journal of Traditional and Complementary Medicine · 5
PDF
Characterization of a novel Leishmania antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine
2025 · Bianca de Oliveira, Wanessa M. Goes, et al. · mSphere · 4
Dissemination of visceral leishmaniasis to Western Argentina: When will imported canine vector-borne zoonotic diseases start being local?
2016 · Roberto Mera y Sierra, Gisela Neira, et al. · Journal of Microbiology Immunology and Infection · 4
PDF
Impact of tumor necrosis factor receptor p55 deficiency in susceptibility of C57BL/6 mice to infection with Leishmania (Leishmania) amazonensis
2014 · Diego Esteban Cargnelutti, María Cristina Salomón, et al. · Journal of Microbiology Immunology and Infection · 4
PDF
Study of Predominant Bacterial Antigens Triggering Antibody Response in Salmonella Reactive Arthritis: Apropos of a Case
2007 · María Gabriela Lacoste, Diego Esteban Cargnelutti, et al. · Japanese Journal of Infectious Diseases · 4
PDF
Reactive arthritis with conjunctivitis, urethritis and diarrhea in a child: immunological study of potential bacterial trigger.
2008 · M G Lacoste, D E Cargnelutti, et al. · PubMed · 3
Works count: 35
Citation count: 296
H-index: 10
I10-index: 12
Year
Topic
Type